NCT03877770

Brief Summary

Patients undergoing electrophysiology studies (EPS) and cardiac ablation procedure for the treatment of cardiac arrhythmias may be at increased risk of deep vein thrombosis (DVT) during or after the procedure, which may lead to pulmonary embolus which can be life threatening. The study will use Doppler ultrasound scanning at 24h and between 10-14 days post EPS and cardiac ablation to assess the incidence of undiagnosed DVT. A positive finding may provide support for a larger clinical trial to assess the benefit of prophylactic anticoagulation post EPS procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

February 15, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 18, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2019

Completed
Last Updated

February 5, 2025

Status Verified

February 1, 2025

Enrollment Period

1.8 years

First QC Date

February 15, 2019

Last Update Submit

February 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of DVT as evidenced by Doppler Ultrasound

    The incidence of DVT in the treated leg will be reported. The study will use Doppler ultrasound scanning post EPS and cardiac ablation to assess the incidence of undiagnosed DVT at up to 14 days post procedure.

    Up to 14 days post procedure.

Secondary Outcomes (3)

  • Elevation of blood markers of DVT in the absence of clinically detectable DVT.

    Blood sampling takes place pre-ablation and 24 hours post procedure.

  • Ultrasound characteristics of the DVT, and change between scans.

    Up to 14 days post procedure.

  • The occurrence of DVT in the untreated leg.

    Up to 14 days post procedure.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred for elective EP study and catheter ablation.

You may qualify if:

  • Patients aged 18 - 80 undergoing elective EP study and catheter ablation
  • Procedure duration between 30 minutes - 4 hours from the time of venous puncture to sheath removal
  • sheaths in a femoral vein

You may not qualify if:

  • Under 18
  • Electrophysiology study only (no ablation performed)
  • Inadequate understanding of spoken English
  • Intubated/ventilated patients
  • Unwilling to give consent to participation OR advised by consultee that this would be against the patient's wishes.
  • Recently treated infection
  • Intravascular implanted cardiac device
  • Prior pacemaker extraction
  • Prior cardiac surgery
  • Previous cardiac ablation within 6 months
  • Documented atrial flutter or atrial fibrillation within 1 year prior to ablation procedure.
  • Participation in a clinical trial of an investigational medicinal product (CTIMP)
  • Documented previous venous thrombosis or pulmonary embolism
  • Known coagulopathy or anticoagulant use
  • Known use of anti-platelet agent
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Blackpool Teaching Hospitals NHS Foundation Trust

Blackpool, Lancashire, United Kingdom

Location

Nottingham University Hospitals NHS Trust

Nottingham, Nottinghamshire, United Kingdom

Location

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, Yorkshire, United Kingdom

Location

Guy's and St Thomas' NHS Foundation Trust

London, United Kingdom

Location

Manchester University NHS Foundation Trust

Manchester, M13 9WU, United Kingdom

Location

Related Publications (1)

  • Bruce C, Saraf K, Rogers S, El-Omar M, Kirkwood G, Kelland NF, Shah D, Chalil S, Fullwood C, Wright M, Jamil-Copley S, Fox D, Abozguia K, Thachil J, McCollum C, Morris GM. Deep Vein Thrombosis is Common After Cardiac Ablation and Pre-Procedural D-Dimer Could Predict Risk. Heart Lung Circ. 2022 Jul;31(7):1015-1022. doi: 10.1016/j.hlc.2022.01.014. Epub 2022 Mar 14.

MeSH Terms

Conditions

ThromboembolismVenous Thrombosis

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular DiseasesCardiovascular DiseasesThrombosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2019

First Posted

March 18, 2019

Study Start

October 20, 2017

Primary Completion

July 31, 2019

Study Completion

July 31, 2019

Last Updated

February 5, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations